Diana Boraschi,
Giselle Penton-Rol
Elsevier Science
e druk, 2016
9780128033029
Immune Rebalancing
The Future of Immunosuppression
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
2016
ISBN13: 9780128033029
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Immune Rebalancing: The Future of Immunosuppression summarizes the most promising perspectives of immunopharmacology, in particular in the area of immunosuppression by considering molecular pathways, personalized medicine, microbiome and nanomedicine.
Modulation of immune responses for therapeutic purposes is a particularly relevant area, given the central role of anomalous immunity in diseases. These diseases vary from the most typically immune-related syndromes (autoimmune diseases, allergy and asthma, immunodeficiencies) to those in which altered immunity and inflammation define the pathological outcomes (chronic infections, tumours, chronic inflammatory and degenerative diseases, metabolic disorders, etc.
Specificaties
Inhoudsopgave
1. Pharmacological strategies using biologics as immunomodulatory agents (Introduction)<br>2: Mechanisms of immune-related pathologies and their current treatment<br>2.1 Rheumatoid arthritis<br>2.2 IBD and Crohn’s disease<br>2.3 MS and neurodegenerative diseases<br>2.4 Allergic diseases<br>2.5 Cancer<br>3: Biologics as immunosuppressive agents <br>3.1 Modulating macrophage activity<br>3.2 Modulatig inflammatory cytokines: IL-1<br>4. Systems medicine and personalised medicine<br>5. Modulation of the microbiome for immune re-balancing<br>6. Natural products<br>7. Nanomedicine